Bionoxx - Crunchbase Company Profile & Funding

Q: Where is Bionoxx's headquarters?

Bionoxx is located in Seongnam, Kyonggi-do, South Korea.

Q: Who invested in Bionoxx?

Bionoxx has 3 investors including Daekyo Investment And Yuanta Investment.

Q: When was the last funding round for Bionoxx?

Bionoxx closed its last funding round on obfuscated from a Series B round.

Overview

Bionoxx

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Bionoxx

CB Rank

152527

Bionoxx is a research and development company that develops immune regulation-based anticancer drugs to conquer cancer diseases.

Founded

obfuscation

Private

Series B

Seongnam, Kyonggi-do, South Korea

11-50

www.bionoxx.com

Biopharma

Clinical Trials

Medical

Pharmaceutical

Funding Rounds

Series B

OBF

obfuscation

Venture - Series Unknown

OBF

obfuscation

Details

Legal Name

Bionoxx, Inc.

Also Known As

Breaking Immuno Oncology

Operating Status

Active

Company Type

For Profit

Phone Number

+82 31719 9179

Contact Email

bionoxx@bionoxx.com

Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

mOTS-400s

An oncolytic vaccinia virus designed to modulate immune dysregulation and target solid tumors for cancer treatment.

UTTA CAR-T

A CAR-T cell therapy targeting Universal Tumor Targeting Antigen (UTTA) expressed on tumor cells after mOTS-400s administration.

Research & Development

Bionoxx is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B
obfuscated obfuscation	Series B - Bionoxx	2	obfuscated obfuscation	—	Series B

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Daekyo Investment	—	Series B - Bionoxx	—
Daekyo Investment	—	Series B - Bionoxx	—
Daekyo Investment	—	Series B - Bionoxx	—
Daekyo Investment	—	Series B - Bionoxx	—
Daekyo Investment	—	Series B - Bionoxx	—